Paper26914280
DNA-crosslinker cisplatin eradicates bacterial persister cells.
Chowdhury N and 4 others. Biotechnol Bioeng, 2016. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. DNA-crosslinker cisplatin eradicates bacterial persister cells. Papers, record 26914280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26914280
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Cisplatin | Major topic |
| Cross-Linking Reagents | Major topic |
| Microbial Viability | Major topic |
| Biofilms | |
| DNA | |
| Escherichia coli | |
| Microbial Sensitivity Tests |
Source PubMed
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42932863 | You got me (un)hooked: Repair of DNA crosslinks in bacteria. | Genet Mol Biol | 2026 | https://conductscience.org/library/papers/42932863 | PubMed |
| 42107646 | Photochemical modification of two fluorene-based molecules with DNA intercalating and anti-methicillin resistant Staphylococcus aureus activity. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42107646 | PubMed |
| 42103893 | A platinum butterfly effect: small changes turn an anticancer drug into a non-toxic metalloantibiotic with in vivo efficacy. | NPJ Antimicrob Resist | 2026 | https://conductscience.org/library/papers/42103893 | PubMed |
| 41520010 | Synergistic antipersister, efflux inhibitory & antibiofilm activities of vaginal Lactobacillus-derived postbiotics against UPEC: toward a novel therapeutic for utis. | Sci Rep | 2026 | https://conductscience.org/library/papers/41520010 | PubMed |
| 41262223 | A Review Vancomycin Role in Gram Positive Biofilm-Associated Infections: Challenges and Emerging Solutions. | Ther Clin Risk Manag | 2025 | https://conductscience.org/library/papers/41262223 | PubMed |
| 41013706 | Periprosthetic joint infection after arthroplasty: advances and future prospects. | J Orthop Surg Res | 2025 | https://conductscience.org/library/papers/41013706 | PubMed |
| 40650109 | Inhibition of (p)ppGpp Synthesis and Membrane Fluidity Modulation by Diosgenin: A Strategy to Suppress Staphylococcus aureus Persister Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650109 | PubMed |
| 40593244 | Sonoporation-enhanced the antibacterial efficacy of aminoglycosides against Gram-negative persisters. | World J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/40593244 | PubMed |
| 39858322 | Glucose Supplementation Enhances the Bactericidal Effect of Penicillin and Gentamicin on Streptococcus sanguinis Persisters. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/39858322 | PubMed |
| 39460765 | Phenotypic heterogeneity in bacteria: the rise of antibiotic persistence, clinical implications, and therapeutic opportunities. | Arch Microbiol | 2024 | https://conductscience.org/library/papers/39460765 | PubMed |
| 39334989 | Mitomycin C as an Anti-Persister Strategy against Klebsiella pneumoniae: Toxicity and Synergy Studies. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39334989 | PubMed |
| 39282194 | Current Strategies for Combating Biofilm-Forming Pathogens in Clinical Healthcare-Associated Infections. | Indian J Microbiol | 2024 | https://conductscience.org/library/papers/39282194 | PubMed |
| 39229839 | Antibiotic heteroresistance and persistence: an additional aid in hospital acquired infections by Enterococcus spp.? | Future Microbiol | 2024 | https://conductscience.org/library/papers/39229839 | PubMed |
| 39061334 | The Many Lives of Auranofin: How an Old Anti-Rheumatic Agent May Become a Promising Antimicrobial Drug. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39061334 | PubMed |
| 39013893 | Bacterial persisters: molecular mechanisms and therapeutic development. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39013893 | PubMed |
| 38436588 | Investigation of Siderophore-Platinum(IV) Conjugates Reveals Differing Antibacterial Activity and DNA Damage Depending on the Platinum Cargo. | ACS Infect Dis | 2024 | https://conductscience.org/library/papers/38436588 | PubMed |
| 38318129 | Antimicrobial activity of nature-inspired molecules against multidrug-resistant bacteria. | Front Microbiol | 2023 | https://conductscience.org/library/papers/38318129 | PubMed |
| 38247634 | Small Schiff Base Molecules-A Possible Strategy to Combat Biofilm-Related Infections. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38247634 | PubMed |
| 38097907 | Biofilm formation: mechanistic insights and therapeutic targets. | Mol Biomed | 2023 | https://conductscience.org/library/papers/38097907 | PubMed |
| 38064019 | Antibiotic Efficacy in Escherichia coli and Klebsiella pneumoniae Under Nutrient Limitation and Effectiveness of Colistin-Based Antibiotic Combinations to Eradicate Persister Cells. | Curr Microbiol | 2023 | https://conductscience.org/library/papers/38064019 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26914280
GET https://conductscience.org/api/papers/v1/26914280/cited_by?page=2